Non-Invasive Prenatal Testing (NIPT) Market Projected to Reach USD 11.39 Billion by 2034, Growing at a CAGR of 9.8%

𝐈𝐧 𝟐𝟎𝟐𝟒, 𝐭𝐡𝐞 𝐧𝐨𝐧-𝐢𝐧𝐯𝐚𝐬𝐢𝐯𝐞 𝐩𝐫𝐞𝐧𝐚𝐭𝐚𝐥 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐰𝐨𝐫𝐭𝐡 𝐔𝐒𝐃 𝟒.𝟒𝟖 𝐛𝐢𝐥𝐥𝐢𝐨𝐧. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐞𝐱𝐩𝐚𝐧𝐝 𝐚𝐭 𝐚 𝐜𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐚𝐧𝐧𝐮𝐚𝐥 𝐠𝐫𝐨𝐰𝐭𝐡 𝐫𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐟 𝟗.𝟖% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟓 𝐭𝐨 𝟐𝟎𝟑𝟒, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐟𝐫𝐨𝐦 𝐔𝐒𝐃 𝟒.𝟗𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟓 𝐭𝐨 𝐔𝐒𝐃 𝟏𝟏.𝟑𝟗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟒.

𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐜𝐨𝐩𝐞:
In order to provide a thorough analysis of the non-invasive prenatal testing market, the research primarily focuses on the most recent trends, top companies, market share, revenue generated, and regional analysis.

𝐆𝐞𝐭 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬 𝐨𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.polarismarketresearch.com/industry-analysis/non-invasive-prenatal-testing-nipt-market/request-for-sample

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐞𝐟𝐢𝐧𝐢𝐭𝐢𝐨𝐧:
A fetus can be screened for genetic abnormalities using a blood test called non-invasive prenatal testing (NIPT). DNA fragments from the placenta and the mother's cells are found in the mother's blood's cell-free DNA (cfDNA), which NIPT examines. Placental cells typically contain DNA that is exactly the same as that of the fetus. The risk of Down syndrome, trisomy 13, trisomy 18, Turner syndrome, Klinefelter syndrome, and triple X syndrome in the fetus can be determined by NIPT. It can also determine the sex of the fetus. Although no screening test is 100% accurate, NIPT is more accurate than the initial pregnancy screening test.

𝐌𝐚𝐣𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬
Many businesses are trying to stand out in this ever-competing market by trying to be innovative. A few of the major key players involved in the non-invasive prenatal testing (NIPT) market are:

• Agilent Technologies, Inc.
• Centogene N.V.
• Eurofins LifeCodexx GmbH
• F. Hoffmann-La Roche Ltd.
• Illumina, Inc.
• Laboratory Corp. of America Holdings
• MedGenome Labs Ltd.
• Myriad Women's Health, Inc.

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
https://www.polarismarketresearch.com/buy/788/0

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬
• The growing prevalence of prenatal genetic disorders and consumer demand for early, precise assessments of fetal health are the primary drivers of the significant growth of the market.
• Effective non-invasive testing has become more important as the prevalence of Down syndrome, Edward's syndrome, and other chromosomal abnormalities has increased.
• Because of ongoing developments in bioinformatics and sequencing technologies, the market is expanding quickly.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
𝐁𝐲 𝐆𝐞𝐬𝐭𝐚𝐭𝐢𝐨𝐧 𝐏𝐞𝐫𝐢𝐨𝐝 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
• 0-12 weeks
• 13-24 weeks
• 25-36 weeks

𝐁𝐲 𝐂𝐨𝐦𝐩𝐨𝐧𝐞𝐧𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
• Consumables
• Instruments
• Software
• Services

𝐁𝐲 𝐌𝐞𝐭𝐡𝐨𝐝 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
• Cell-Free DNA in Maternal Plasma Tests
• Ultrasound Detection
• Biochemical Screening Tests
• Others

𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
• Monosomy
• Trisomy
• Microdeletion Syndrome
• Others

𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤
• Diagnostic Centers
• Hospitals and Clinics
• Others

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬
• In 2024, the North America non-invasive prenatal testing market held the largest revenue share owing to its sophisticated healthcare system, high level of awareness, and strong adoption of advanced technologies.
• The market for non-invasive prenatal testing in Asia Pacific is anticipated to grow at the fastest rate between 2025 and 2034. This expansion is largely driven by economic growth, with increased disposable incomes and improved healthcare spending leading to higher adoption rates.

o North America (U.S., Canada)
o Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
o Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
o Latin America (Brazil, Mexico, Argentina)
o Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

𝐌𝐨𝐫𝐞 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Geriatric Medicines Market
https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market

Xerostomia Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/xerostomia-therapeutics-market

Inflammatory Bowel Disease (Ibd) Market
https://www.polarismarketresearch.com/industry-analysis/global-inflammatory-bowel-disease-ibd-market

Leukemia Therapeutics Market
https://www.polarismarketresearch.com/industry-analysis/global-leukemia-therapeutics-market

Multiple Sclerosis Market
https://www.polarismarketresearch.com/industry-analysis/global-multiple-sclerosis-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

𝐀𝐛𝐨𝐮𝐭 𝐏𝐨𝐥𝐚𝐫𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 & 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠, 𝐈𝐧𝐜:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.